BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 7708681)

  • 1. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
    Harris ZL; Takahashi Y; Miyajima H; Serizawa M; MacGillivray RT; Gitlin JD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2539-43. PubMed ID: 7708681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The copper-iron connection: hereditary aceruloplasminemia.
    Nittis T; Gitlin JD
    Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aceruloplasminemia, an inherited disorder of iron metabolism.
    Miyajima H; Takahashi Y; Kono S
    Biometals; 2003 Mar; 16(1):205-13. PubMed ID: 12572680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease.
    Takahashi Y; Miyajima H; Shirabe S; Nagataki S; Suenaga A; Gitlin JD
    Hum Mol Genet; 1996 Jan; 5(1):81-84. PubMed ID: 8789443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL; Klomp LW; Gitlin JD
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma lipid peroxidation in patients with aceruloplasminemia.
    Miyajima H; Takahashi Y; Serizawa M; Kaneko E; Gitlin JD
    Free Radic Biol Med; 1996; 20(5):757-60. PubMed ID: 8721620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aceruloplasminemia.
    Gitlin JD
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the gene frequency of aceruloplasminemia in Japan.
    Miyajima H; Kohno S; Takahashi Y; Yonekawa O; Kanno T
    Neurology; 1999 Aug; 53(3):617-9. PubMed ID: 10449129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
    Kono S; Suzuki H; Takahashi K; Takahashi Y; Shirakawa K; Murakawa Y; Yamaguchi S; Miyajima H
    Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
    Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis.
    Yazaki M; Yoshida K; Nakamura A; Furihata K; Yonekawa M; Okabe T; Yamashita N; Ohta M; Ikeda S
    J Neurol Sci; 1998; 156(1):30-4. PubMed ID: 9559983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary ceruloplasmin deficiency with hemosiderosis.
    Okamoto N; Wada S; Oga T; Kawabata Y; Baba Y; Habu D; Takeda Z; Wada Y
    Hum Genet; 1996 Jun; 97(6):755-8. PubMed ID: 8641692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux.
    Harris ZL; Durley AP; Man TK; Gitlin JD
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10812-7. PubMed ID: 10485908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
    J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma.
    Yonekawa M; Okabe T; Asamoto Y; Ohta M
    Eur Neurol; 1999; 42(3):157-62. PubMed ID: 10529542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.